PRIMARY STUDY
Regional Changes in the Type 1 Cannabinoid Receptor Are Associated With Cognitive Dysfunction in Parkinson's Disease
Key Findings: PET scan of participating Parkinson's patients showed decreased CB1 receptor sites in portions of the brain strongly correlated with ill-effects in executive functioning, episodic memory, and visuospatial functioning.
Type of Study: Meta-analysis
Study Sample Size: 38
Study Result: Inconclusive
Research Location(s): Belgium
Year of Pub: 2019
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1
Citation: Ceccarini J, et al. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease. Eur J Nucl Med Mol Imaging. 2019; 46:2348-2357. doi: 10.1007/s00259-019-04445-x
Authors: Ceccarini J, Casteels C, Ahmad R, Crabbé M, Van de Vliet L, Vanhaute H, Vandenbulcke M, Vandenberghe W, Van Laere K
